https://www.selleckchem.com/pr....oducts/Resveratrol.h
Catheter ablation is increasingly used to treat atrial fibrillation (AF), the most common sustained cardiac arrhythmia encountered in clinical practice. A recent breakthrough finding in AF ablation consists in identifying ablation sites based on their spatiotemporal dispersion (STD). STD stands for a delay of the cardiac activation observed in intracardiac electrograms (EGMs) across contiguous leads. In practice, interventional cardiologists localize STD sites visually using the PentaRay multipolar mapping catheter. This work aims a